Laboratories that wish to perform the analysis of doping controls for sports under the World Anti-Doping Code must achieve and maintain accreditation from WADA. The International Standard for Laboratories ISL and its related technical documents specify the criteria that must be met for accreditation and re-accreditation, as well as standards that must be met for the production of valid test results and evidentiary data.
To fully serve the development of the Athlete Biological Passport (ABP), particularly in regions where the current network of WADA-accredited laboratories may be limited, WADA has approved these laboratories to conduct blood analyses in support of the APB.
WADA publishes, from time to time, specific technical recommendations, addressing particular operational areas of the accredited laboratories, in a Technical Document.
The Technical Documents constitute level-2 elements of the World Anti-Doping Program, and therefore implementation of the technical recommendations described in them is mandatory and must occur by the effective date specified in the Technical Document.
Technical Documents supersede any previous publication on a similar topic, or if applicable, the International Standard for Laboratories (ISL). The document in effect is the Technical Document whose effective date most recently precedes that of sample receipt date by the laboratory.
Technical Documents In Effect
(in alphabetical order)
|Summary of modifications||Effective Date*|
|TD2017 BAR||1 Jan. 2017|
|TD2017 CG/LH||TD2017 CG/LH - Summary Modifications||1 Sep. 2017|
|TD2017 DL Version 2||TD2017 DL Version 2 - Summary of Modifications||1 Sep. 2017|
|TD2016 EAAS||TD2016 EAAS - Summary of Modifications||1 Jan. 2016|
|TD2014 EPO||TD2014 EPO - Summary of Modifications||1 Sep. 2014|
|TD2015 GH||1 Sep. 2015|
|TD2015 IDCR||TD2015 IDCR - Summary of Modifications||1 Sep. 2015|
|TD2016 IRMS||TD2016 IRMS - Summary of Modifications||1 Jan. 2016|
|TD2009 LCOC||1 Jan. 2009|
|TD2017 LDOC||TD2017 LDOC - Summary of Modifications||1 May 2017|
|TD2017 MRPL||TD2017 MRPL - Summary of Modifications||1 Sep. 2017|
|TD2017 NA||TD2017 NA - Summary of Modifications||1 Sep. 2017|
* Deadline for implementation
In cooperation with WADA, the International Anti-Doping Agreement (IADA) has also developed guidelines for Anti-Doping Organizations that have already obtained an ISO certification or that wish to be ISO-certified. These are: Guidelines for Transition and Guidelines for Certification.
As with all guidelines under the World Anti-Doping Program, these documents are subject to ongoing review and reassessment.
WADA encourages feedback on the content of the Guidelines, and recommends that stakeholders always consult this Web site for the latest version.
Laboratory Guidelines currently in force:
- Human Growth Hormone (hGH) Biomarkers Test
- TUE enquiries by Accredited Laboratories
- Laboratory Test Reports
LABORATORY TESTING FIGURES
In accordance with Article 14.5 of the World Anti-Doping Code (the Code), WADA, acting as a central clearinghouse for Doping Control data, annually publishes statistical reports as reported by the WADA accredited laboratories in the Anti-Doping Administration and Management System (ADAMS).
The latest WADA Anti-Doping Testing Figures Report can be accessed here.
For a more complete overview of the Testing Figures, please consult the comprehensive Questions and Answers document.
Collaboration between WADA and the International Laboratory Accreditation Cooperation (ILAC) provides an important opportunity to conduct the International Standard for Laboratories (ISL) assessment concurrently with the ISO/IEC 17025 assessment for the WADA accredited anti-doping laboratories.
The List of ISL Assessors contains the names of the assessors from ILAC-member accreditation bodies trained by WADA for
the ISL assessment.